THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS IT HAS BEEN REGISTERED UNDER THE ACT AND SUCH LAWS OR (1)...Purchase Preferred Stock • December 23rd, 2013 • Genocea Biosciences, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Warrant is one of the “Financing Warrants” referred to in that certain Note Purchase Agreement, dated as of January 7, 2008 (as amended, restated or otherwise modified from time to time, the “Note Purchase Agreement”), among the Company and the Purchasers from time to time party thereto and is subject to the terms and conditions set forth therein with respect hereto, which terms and conditions are incorporated herein by reference. The Holder hereof is entitled to the benefits and subject to the conditions set forth in the Note Purchase Agreement and may enforce the agreements of the Company contained therein, and exercise the respective remedies provided for thereby or otherwise available in respect hereof, all in accordance with the respective terms thereof. Capitalized terms used herein but not otherwise defined herein shall have the meanings assigned thereto in the Note Purchase Agreement.
SEASTAR MEDICAL, INC. AMENDMENT TO WARRANT TO PURCHASE PREFERRED STOCKPurchase Preferred Stock • September 21st, 2022 • LMF Acquisition Opportunities Inc • Surgical & medical instruments & apparatus • Delaware
THIS AMENDMENT TO THE WARRANT TO PURCHASE PREFERRED STOCK (this “Amendment”) is made and entered into as of [ ], 2022 by and between SeaStar Medical, Inc., a Delaware corporation (the “Company”) and the holder set forth on the signature page hereto (the “Holder”).
AMENDMENT OF WARRANT TO PURCHASE PREFERRED STOCKPurchase Preferred Stock • September 23rd, 2013 • Biocept Inc • Services-medical laboratories
This Amendment of Warrant to Purchase Preferred Stock is entered into as of September 13, 2013 between Biocept, Inc., a Delaware corporation (“Biocept”) and (the “Holder”) with respect to each and every Warrant to Purchase Preferred Stock (collectively referred to herein in the singular as the “Warrant”) issued by Biocept’s predecessor Biocept, Inc., a California corporation, to the Holder under the Note and Warrant Purchase Agreement dated as of January 13, 2012 and any and all amendments of such Note and Warrant Purchase Agreement.
ICO GLOBAL COMMUNICATIONS (HOLDINGS) LIMITEDPurchase Preferred Stock • September 5th, 2020 • New York
TAX BENEFITS PRESERVATION PLAN, dated as of January 29, 2010 (the “Plan”), between ICO Global Communications (Holdings) Limited, a Delaware corporation (the “Company”), and Mellon Investor Services LLC (operating with the service name BNY Mellon Shareowner Services), a New Jersey limited liability company, as rights agent (the “Rights Agent”).
ContractPurchase Preferred Stock • December 9th, 2011 • Mascoma Corp • Industrial organic chemicals • California
THIS AMENDED AND RESTATED WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 8 OF THIS AMENDED AND RESTATED WARRANT.
